Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
AUTHORS
Bedse
G ,
Bluet
RJ ,
Patrick
TA ,
Romness
KN ,
Gaulden
AD ,
Kingsley
PJ ,
Plath
N ,
Marnett
LJ ,
Patel
S .
Translational Psychiatry. 2018 4 26; 8(1).
- PMID: 29695817[PubMed].
- PMCID: PMC5917016.